Peutz-Jegher syndrome in childhood: need for updated recommendations?

Stephanie A Goldstein1, Edward J Hoffenberg

  • 1University of Colorado School of Medicine, Aurora, CO, USA.

Insights

Children with Peutz-Jegher syndrome (PJS) often develop significant polyps before age 8. Early screening for PJS is recommended at age 4-5 to detect complications and guide management.

Area of Science:

  • Pediatric Gastroenterology
  • Genetics
  • Oncology

Background:

  • Peutz-Jegher syndrome (PJS) is a rare genetic disorder.
  • It increases the risk of various cancers and gastrointestinal complications.
  • Current screening guidelines for children with PJS may need revision.

Purpose of the Study:

  • To review institutional experience with pediatric Peutz-Jegher syndrome.
  • To evaluate the optimal timing for screening and follow-up in children with PJS.
  • To inform potential modifications to current clinical guidelines.

Main Methods:

  • Retrospective chart review of pediatric PJS patients (2000-2011).
  • Data abstracted included intussusception events, polyp characteristics, Sertoli cell tumors, family history, imaging, and interventions.
  • Analysis focused on age at presentation, screening, polyp detection, and complications.

Main Results:

  • 14 children with PJS were identified; median age at first evaluation was 4.5 years.
  • Screening began at a median age of 5 years, with polyps identified early.
  • Significant clinical consequences, including intussusception and Sertoli cell tumors, occurred in children younger than 8 years.

Conclusions:

  • Polyps causing significant clinical issues are common in children with PJS under 8 years old.
  • Revised guidelines should recommend initial screening at age 4-5.
  • Screening should include capsule endoscopy, upper/lower endoscopy, and evaluation for Sertoli cell tumors.
Abstract

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...